Literature DB >> 2283579

A matched comparison of adjustment in children with cystic fibrosis and psychiatrically referred and nonreferred children.

R J Thompson1, K Hodges, K W Hamlett.   

Abstract

Utilized the Child Assessment Schedule, a standardized clinical interview, to assess psychosocial adjustment in terms of DSM-III diagnoses. The criteria for a major DSM-III diagnosis were met by 58% of the children with cystic fibrosis compared to 23% for the nonreferred children and 77% for the psychiatrically referred children. Children with cystic fibrosis generally did not demonstrate more symptoms of psychological disturbance than nonreferred children. It was in terms of worries, poor self-image, and anxiety, that the children with cystic fibrosis demonstrated symptom levels comparable to that of psychiatrically referred children. Findings are discussed in terms of the specific risk of internalizing behavior problems for children with chronic illness.

Entities:  

Mesh:

Year:  1990        PMID: 2283579     DOI: 10.1093/jpepsy/15.6.745

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  3 in total

1.  The impact of medical comorbidity on mental health and functional health outcomes among children with anxiety disorders.

Authors:  Denise A Chavira; Ann F Garland; Sandra Daley; Richard Hough
Journal:  J Dev Behav Pediatr       Date:  2008-10       Impact factor: 2.225

2.  Health-related quality of life in adolescents with inflammatory bowel disease depends on disease activity and psychiatric comorbidity.

Authors:  G Engelmann; D Erhard; M Petersen; P Parzer; A A Schlarb; F Resch; R Brunner; G F Hoffmann; H Lenhartz; A Richterich
Journal:  Child Psychiatry Hum Dev       Date:  2015-04

3.  Effect of the COVID-19 pandemic on anxiety among children with cystic fibrosis and their mothers.

Authors:  Burcu Pınar Senkalfa; Tugba Sismanlar Eyuboglu; Ayse T Aslan; Tugba Ramaslı Gursoy; Azime S Soysal; Dilek Yapar; Mustafa N İlhan
Journal:  Pediatr Pulmonol       Date:  2020-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.